BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21402402)

  • 1. RE: "Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers".
    Fagotti A; Vizzielli G; Scambia G
    Gynecol Oncol; 2011 Jul; 122(1):201; author reply 201-2. PubMed ID: 21402402
    [No Abstract]   [Full Text] [Related]  

  • 2. Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers.
    Long KC; Levinson KL; Diaz JP; Gardner GJ; Chi DS; Barakat RR; Leitao MM
    Gynecol Oncol; 2011 Jan; 120(1):33-7. PubMed ID: 20947151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced cytoreductive surgery: American perspective.
    Zivanovic O; Aldini A; Carlson JW; Chi DS
    Gynecol Oncol; 2009 Aug; 114(2 Suppl):S3-9. PubMed ID: 19573703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
    Chi DS; Zivanovic O; Levinson KL; Kolev V; Huh J; Dottino J; Gardner GJ; Leitao MM; Levine DA; Sonoda Y; Abu-Rustum NR; Brown CL; Barakat RR
    Gynecol Oncol; 2010 Oct; 119(1):38-42. PubMed ID: 20609464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers.
    Krill LS; Ueda SM; Gerardi M; Bristow RE
    Gynecol Oncol; 2011 Feb; 120(2):220-3. PubMed ID: 21145096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is minimal invasive surgery for primary and secondary debulking of ovarian/peritoneal/fallopian tube cancer going too far?
    Gorostidi M
    Int J Gynecol Cancer; 2014 Sep; 24(7):1138-9. PubMed ID: 25054450
    [No Abstract]   [Full Text] [Related]  

  • 7. Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
    Shih KK; Chi DS; Barakat RR; Leitao MM
    Gynecol Oncol; 2010 Mar; 116(3):364-9. PubMed ID: 19897231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers.
    Jeon S; Lee SJ; Lim MC; Song T; Bae J; Kim K; Lee JY; Kim SW; Chang SJ; Lee JM
    J Gynecol Oncol; 2017 Jan; 28(1):e6. PubMed ID: 27670260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers.
    Nezhat FR; DeNoble SM; Liu CS; Cho JE; Brown DN; Chuang L; Gretz H; Saharia P
    JSLS; 2010; 14(2):155-68. PubMed ID: 20932362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study.
    Spirtos NM; Eisekop SM; Boike G; Schlaerth JB; Cappellari JO
    Am J Obstet Gynecol; 2005 Nov; 193(5):1645-9. PubMed ID: 16260204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.
    Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.
    Black D; Iasonos A; Ahmed H; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2007 Oct; 107(1):66-70. PubMed ID: 17614125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.
    Chi DS; Franklin CC; Levine DA; Akselrod F; Sabbatini P; Jarnagin WR; DeMatteo R; Poynor EA; Abu-Rustum NR; Barakat RR
    Gynecol Oncol; 2004 Sep; 94(3):650-4. PubMed ID: 15350354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer.
    Bashir S; Gerardi MA; Giuntoli RL; Montes TP; Bristow RE
    Gynecol Oncol; 2010 Nov; 119(2):255-8. PubMed ID: 20739051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
    Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
    Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
    Lan C; Li Y; Liu J
    Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience.
    Peiretti M; Zanagnolo V; Aletti GD; Bocciolone L; Colombo N; Landoni F; Minig L; Biffi R; Radice D; Maggioni A
    Gynecol Oncol; 2010 Nov; 119(2):259-64. PubMed ID: 20800269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers.
    Leitao MM; Natenzon A; Abu-Rustum NR; Chi DS; Sonoda Y; Levine DA; Gardner GJ; Barakat RR
    Gynecol Oncol; 2009 Nov; 115(2):204-8. PubMed ID: 19740532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.